The summer July/August issue of PME leads on how brand teams can bring more value to their customers, with an extended article authored by AstraZeneca and Strategic North.
We hear from Carol Lynch, the recently elected chair of the European Generics Medicines Association, on whether biosimilars can live up to the hype. Carol, who’s also global head of biopharmaceuticals and oncology injectables at Sandoz, says it’s time for all stakeholders to step up.
Inevitably we’re also looking at what the UK’s Brexit vote to leave the European Union will mean for the pharmaceutical industry – and do get in touch if you would like to share your thoughts on the referendum’s unexpected outcome.
Elsewhere in this issue you can also hear from HBA Europe’s Claudia Graeve and Kathrin Schoenborn-Sobolweski on their group’s efforts to further women’s advancement in healthcare.
Among this issue’s other gems there’s a look at future directions in immunotherapy, changes in asthma and allergies and questions are raised about patient involvement in the value debate.
View PME July/August 2016 online
Register here to receive email notification of future digital editions of PME or contact the subscriptions department to enquire about receiving a print copy of the magazine. More PMLiVE digital editions can be found here.
PME is also available to download as an app for iPhone and iPad
